Riskpilot← Back to searchSign inGet full accessAktiveraKliniken AB
ABActiveOrg 5567584486Dag Hammarskjölds Väg 58 CPhysiotherapy activities · NACE 8695Est. 20082 employees
Revenue 2025
SEK 2,4M
+4% vs 2024
EBITDA margin
4.4%
+1181% vs 2024
Equity ratio
20.4%
Financial strength
Net profit 2025
SEK 24K
+124% vs 2024
| Revenue | SEK 2,4M | +4% |
| EBITDA | SEK 107K | +1181% |
| Net profit | SEK 24K | +124% |
| Total assets | SEK 561K | -20% |
| Equity | SEK 115K | +26% |
| Employees | 2 | — |
Legal name
AktiveraKliniken AB
Org number
5567584486
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
24 maj 2008
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva hälso och sjukvård, friskvård, undervisning inom hälso- och sjukvård, träning och skidlärarverksamhet samt därmed förenlig verksamhet.
Address
Dag Hammarskjölds Väg 58 C
Email
tobias@aktiverakliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 966 | 2 029 | 2 131 | 2 321 | 2 410 |
| Staff expenses | — | −1 207 | −1 205 | −1 331 | −1 403 |
| EBITDA | 222 | 10 | −208 | 8 | 107 |
| Depreciation & amort. | −107 | −109 | −106 | −79 | −12 |
| EBIT | 115 | −99 | −314 | −70 | 95 |
| Net financials | −6 | −5 | −8 | −29 | −72 |
| Profit before tax | 109 | −104 | −322 | −99 | 24 |
| Tax | −37 | — | — | — | — |
| Net profit | 72 | −104 | −322 | −99 | 24 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 234 | 1 285 | 947 | 700 | 561 |
| Equity | 736 | 632 | 190 | 91 | 115 |
| Long-term debt | 0 | 300 | 300 | 103 | 88 |
| Short-term debt | 379 | 156 | 258 | 307 | 198 |
| Total debt | 379 | 456 | 558 | 410 | 286 |
EBITDA margin
4.4%
This company
15.8%
Market median
-72% vs market
20212025
Equity ratio
20.4%
This company
38.2%
Market median
-47% vs market
20212025
Return on equity
20.7%
This company
18.4%
Market median
+13% vs market
20212025
Net profit margin
1.0%
This company
8.1%
Market median
-88% vs market
20212025
Asset turnover
4.30×
This company
1.12×
Market median
+284% vs market
20212025
Debt / equity
3.90×
This company
0.62×
Market median
-529% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TT Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AktiveraKliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tobias Tolve Nyman | Chief Executive Officer | 0 companies |
| Bondpä Jennie C Kvintåhs Eriksson | Deputy Board Member | 0 companies |
| Lars-Göran Karl Henry Nyman | Deputy Board Member | 0 companies |